121 related articles for article (PubMed ID: 8279777)
1. A new schedule for clodronate treatment in patients with breast cancer and bone metastases.
Beghé F; Luzzani M
Ann N Y Acad Sci; 1993 Nov; 698():367-71. PubMed ID: 8279777
[No Abstract] [Full Text] [Related]
2. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
Bull Cancer; 1993; 80(10 Suppl):50-6. PubMed ID: 8081032
[No Abstract] [Full Text] [Related]
3. Disodium clodronate in the treatment of pain due to bone metastases.
Luzzani M; Vidili MG; Rissotto R; Nobile MT; Beghè F; Rosso R; Gottlieb A
Int J Clin Pharmacol Res; 1990; 10(4):243-6. PubMed ID: 2150406
[TBL] [Abstract][Full Text] [Related]
4. Clodronate : a review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer.
Dando TM; Wiseman LR
Drugs Aging; 2004; 21(14):949-62. PubMed ID: 15554753
[TBL] [Abstract][Full Text] [Related]
5. Subjective and metabolic effects of clodronate in patients with advanced breast cancer and symptomatic bone metastases.
Neri B; Gemelli MT; Sambataro S; Colombi L; Benvenuti F; Ludovici M; Pacini P
Anticancer Drugs; 1992 Apr; 3(2):87-90. PubMed ID: 1388063
[TBL] [Abstract][Full Text] [Related]
6. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
Moiseenko VM; Blinov NN; Semiglazov VV; Konstantinova MM; Trishkina EA
Vopr Onkol; 1998; 44(6):725-8. PubMed ID: 10087976
[TBL] [Abstract][Full Text] [Related]
7. Oral clodronate in breast cancer patients with bone metastases: a randomized study.
Kristensen B; Ejlertsen B; Groenvold M; Hein S; Loft H; Mouridsen HT
J Intern Med; 1999 Jul; 246(1):67-74. PubMed ID: 10447227
[TBL] [Abstract][Full Text] [Related]
8. Reduction in new metastases in breast cancer with adjuvant clodronate treatment.
Diel IJ; Solomayer EF; Costa SD; Gollan C; Goerner R; Wallwiener D; Kaufmann M; Bastert G
N Engl J Med; 1998 Aug; 339(6):357-63. PubMed ID: 9691101
[TBL] [Abstract][Full Text] [Related]
9. Clodronate decreases the frequency of skeletal metastases in women with breast cancer.
Kanis JA; Powles T; Paterson AH; McCloskey EV; Ashley S
Bone; 1996 Dec; 19(6):663-7. PubMed ID: 8968035
[TBL] [Abstract][Full Text] [Related]
10. Clodronate for osteolytic metastases due to breast cancer.
Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
[TBL] [Abstract][Full Text] [Related]
11. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström GH
Bone; 1987; 8 Suppl 1():S53-6. PubMed ID: 2961355
[TBL] [Abstract][Full Text] [Related]
12. Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Rotstein S; Glas U; Eriksson M; Pfeiffer P; Hansen J; Söderqvist J; Bandmann U; Strid S
Eur J Cancer; 1992; 28A(4-5):890-3. PubMed ID: 1388038
[TBL] [Abstract][Full Text] [Related]
13. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.
Saarto T; Blomqvist C; Virkkunen P; Elomaa I
J Clin Oncol; 2001 Jan; 19(1):10-7. PubMed ID: 11134190
[TBL] [Abstract][Full Text] [Related]
15. Reduction of visible bone metastases by clodronate therapy in breast cancer.
Tjalma WA; Buytaert PM; Berneman ZN
Eur J Gynaecol Oncol; 2001; 22(3):215-6. PubMed ID: 11501775
[TBL] [Abstract][Full Text] [Related]
16. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
Kylmälä T; Tammela TL; Lindholm TS; Seppänen J
Ann Chir Gynaecol; 1994; 83(4):316-9. PubMed ID: 7537482
[TBL] [Abstract][Full Text] [Related]
17. Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.
Powles T; Paterson S; Kanis JA; McCloskey E; Ashley S; Tidy A; Rosenqvist K; Smith I; Ottestad L; Legault S; Pajunen M; Nevantaus A; Männistö E; Suovuori A; Atula S; Nevalainen J; Pylkkänen L
J Clin Oncol; 2002 Aug; 20(15):3219-24. PubMed ID: 12149294
[TBL] [Abstract][Full Text] [Related]
18. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
J Clin Oncol; 1993 Jan; 11(1):59-65. PubMed ID: 8418243
[TBL] [Abstract][Full Text] [Related]
19. [Is pamidronate or clodronate better?].
Adam Z
Vnitr Lek; 2002 Apr; 48(4):357. PubMed ID: 12075601
[No Abstract] [Full Text] [Related]
20. Treatment of skeletal disease in breast cancer with clodronate.
Paterson AH; Ernst DS; Powles TJ; Ashley S; McCloskey EV; Kanis JA
Bone; 1991; 12 Suppl 1():S25-30. PubMed ID: 1720012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
